AC Immune SA - SHS (ACIU)

Historical Portfolio Holders from Q3 2016 to Q1 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	27.6 M	$81.6 M	-$1.86 M	137 K	275 K	$2.96	34
2023 Q4	27.9 M	$139 M	+$66.2 M	248 K	392 K	$5.00	32
2023 Q3	16 M	$45.5 M	-$164 K	162 K	141 K	$2.85	26
2023 Q2	16 M	$47.4 M	+$6.28 M	61.9 K	710 K	$2.96	32
2023 Q1	14.1 M	$33 M	-$1.22 M	1.64 K	21.5 K	$2.34	32
2022 Q4	14.8 M	$30.1 M	+$1.54 M	13.3 K	7.14 K	$2.04	35
2022 Q3	14 M	$44.3 M	+$518 K	48 K	106 K	$3.16	31
2022 Q2	13.8 M	$49.8 M	-$1.93 M	74 K	60 K	$3.61	30
2022 Q1	14.3 M	$57.2 M	-$3.45 M	438 K	910 K	$4.00	34
2021 Q4	15 M	$74.5 M	-$21.8 M	412 K	308 K	$4.95	42
2021 Q3	17.6 M	$118 M	-$4.03 M	957 K	1.65 M	$6.71	64
2021 Q2	18.2 M	$144 M	+$814 K	1.34 M	2.06 M	$7.93	58
2021 Q1	18.2 M	$139 M	-$11.3 M	2.18 M	1.64 M	$7.61	51
2020 Q4	18.8 M	$97.2 M	-$3.66 M	671 K	965 K	$5.17	42
2020 Q3	20.7 M	$101 M	+$1.42 M	789 K	2.19 M	$4.88	47
2020 Q2	20.4 M	$137 M	+$1.37 M			$6.73	38
2020 Q1	20.1 M	$139 M	+$7.08 M			$6.91	46
2019 Q4	19.1 M	$163 M	+$3.26 M			$8.52	48
2019 Q3	18.8 M	$93 M	+$3.3 M			$4.95	36
2019 Q2	16.6 M	$92.4 M	+$5.73 M			$5.55	37
2019 Q1	17.8 M	$90.1 M	-$29.8 M			$5.05	38
2018 Q4	20.2 M	$191 M	+$11.5 M			$9.45	38
2018 Q3	19.1 M	$153 M	+$63.5 M			$8.00	32
2018 Q2	11 M	$102 M	-$2.77 M			$9.31	15
2018 Q1	11.3 M	$117 M	+$957 K			$10.34	18
2017 Q4	11.2 M	$143 M	+$18.3 M			$12.80	21
2017 Q3	9.74 M	$110 M	-$3.31 M			$11.24	15
2017 Q2	10.3 M	$90.4 M	-$2.13 M			$8.80	17
2017 Q1	10.5 M	$109 M	+$17.8 M			$10.36	19
2016 Q4	8.75 M	$113 M	+$8.28 M			$12.98	19
2016 Q3	8.24 M	$131 M	+$131 M			$16.47	32